Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Gypenoside XLIX
Cat. No.:
0225LY-0882
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Gynostemsma pentaphyllum extract is derived from the whole herb of the namesake plant and should be maintained in a cool, dry, and sealed environment.
Synonym:
94987-08-3; MFCD22124996
CAS No.:
94987-08-3
Compound CID:
16007240
Formula:
C52H86O21
Formula Weight:
1047.23
Specification
Relative Density:
1.41 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Gypenoside XLIX can be used in hepatology research to explore its protective effects against liver injury via PPAR alpha activation.
Library Information
Target:
PPAR
Receptor:
PPARα
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-12
Plate Location:
c11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 47.75 mM
